MX2009005114A - Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus. - Google Patents

Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus.

Info

Publication number
MX2009005114A
MX2009005114A MX2009005114A MX2009005114A MX2009005114A MX 2009005114 A MX2009005114 A MX 2009005114A MX 2009005114 A MX2009005114 A MX 2009005114A MX 2009005114 A MX2009005114 A MX 2009005114A MX 2009005114 A MX2009005114 A MX 2009005114A
Authority
MX
Mexico
Prior art keywords
gabapentin
pregabalin
prodrugs
treating tinnitus
pregabalin prodrugs
Prior art date
Application number
MX2009005114A
Other languages
English (en)
Inventor
Noa Zerangue
Original Assignee
Xenoport Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenoport Inc filed Critical Xenoport Inc
Publication of MX2009005114A publication Critical patent/MX2009005114A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen métodos para utilizar profármacos de gabapentina y pregabalina y composiciones farmacéuticas de los mismos para tratar tinnitus, y composiciones farmacéuticas de profármacos de gabapentina o pregabalina útiles para tratar tinnitus.
MX2009005114A 2006-11-14 2007-11-13 Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus. MX2009005114A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85928306P 2006-11-14 2006-11-14
PCT/US2007/023944 WO2008060572A1 (en) 2006-11-14 2007-11-13 Use of gabapentin and pregabalin prodrugs for treating tinnitus

Publications (1)

Publication Number Publication Date
MX2009005114A true MX2009005114A (es) 2009-07-16

Family

ID=39111439

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005114A MX2009005114A (es) 2006-11-14 2007-11-13 Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus.

Country Status (9)

Country Link
US (1) US20080188562A1 (es)
EP (1) EP2086530A1 (es)
CN (1) CN101616664A (es)
AU (1) AU2007319851A1 (es)
BR (1) BRPI0718754A2 (es)
CA (1) CA2669246A1 (es)
EA (1) EA200970483A1 (es)
MX (1) MX2009005114A (es)
WO (1) WO2008060572A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7025745B2 (en) * 2002-10-07 2006-04-11 Advanced Cardiovascular Systems, Inc. Method of making a catheter balloon using a tapered mandrel
KR20060119971A (ko) * 2003-09-11 2006-11-24 제노포트 인코포레이티드 Ｇａｂａ 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방
SG147437A1 (en) * 2003-10-14 2008-11-28 Xenoport Inc Crystalline form of gamma-aminobutyric acid analog
MX2007005306A (es) 2004-11-04 2007-06-11 Xenoport Inc Formas de dosis oral de liberacion sostenida de la prodroga gabapentina.
MX2007012688A (es) * 2005-04-15 2008-03-14 Synta Pharmaceuticals Corp Terapia de combinacion para el cancer con compuestos de bis(tiohidrazida) amida.
US20080161393A1 (en) * 2006-12-08 2008-07-03 Barrett Ronald W Use of prodrugs of GABA analogs for treating disease
TWI369982B (en) * 2007-01-11 2012-08-11 Xenoport Inc Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment
KR20110117216A (ko) * 2009-03-03 2011-10-26 제노포트 인코포레이티드 Ｒ-바클로펜 전구약물의 서방형 경구 투약 형태
US20110130454A1 (en) * 2009-11-24 2011-06-02 Xenoport, Inc. Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
EP2530072A1 (en) 2011-06-03 2012-12-05 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
CN105777586A (zh) * 2016-04-14 2016-07-20 安徽省逸欣铭医药科技有限公司 S（+）氨己烯酸酯衍生物及其制备方法和用途
WO2022256545A1 (en) * 2021-06-04 2022-12-08 Nevakar Injectables Inc. Injectable pregabalin formulations
WO2025166193A1 (en) * 2024-02-02 2025-08-07 Regents Of The University Of Minnesota Systems and methods for bimodal neuromodulation for tinnitus treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818787B2 (en) * 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) * 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CN1625393A (zh) * 2002-01-31 2005-06-08 沃纳-兰伯特公司 治疗耳鸣的α2δ配体
AU2003222033A1 (en) * 2002-03-20 2003-10-08 Xenoport Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
US7662987B2 (en) * 2003-07-15 2010-02-16 Xenoport, Inc. Methods for synthesis of acyloxyalkyl compounds
EP1670750A1 (en) * 2003-09-25 2006-06-21 Warner-Lambert Company LLC Prodrugs of amino acids with affinity for the alpha2delta- protein

Also Published As

Publication number Publication date
EA200970483A1 (ru) 2009-12-30
WO2008060572A1 (en) 2008-05-22
CA2669246A1 (en) 2008-05-22
US20080188562A1 (en) 2008-08-07
CN101616664A (zh) 2009-12-30
BRPI0718754A2 (pt) 2013-12-03
AU2007319851A1 (en) 2008-05-22
EP2086530A1 (en) 2009-08-12

Similar Documents

Publication Publication Date Title
MX2009005114A (es) Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus.
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
NO20090157L (no) Tienpyrimidiner anvendelige som modulatorer av ionekanaler
MX349796B (es) Composiciones farmacéuticas para usarse en el tratamiento de trastornos oncológicos mediante el uso de coenzima q10.
PH12014500053A1 (en) Proteasome inhibitors
MY162514A (en) Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
MY160041A (en) Compositions and methods for treating parasitic infections
TN2009000292A1 (en) Formulations for cancer treatment
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
MX342128B (es) Compuestos farmaceuticos.
EP1987141A4 (en) COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-CONDITIONAL DISEASES
PH12014500075A1 (en) Pharmaceutical composition, methods for treating and uses thereof
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
MY154000A (en) Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
MX2011011950A (es) Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas.
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
MX340484B (es) Metodo para reducir daños por quemaduras de sol en las plantas.
MX2008011633A (es) Aminoquinolonas como inhibidores de gsk-3.
MXPA05010515A (es) Tratamiento o prevencion de sofocos calientes utilizando profarmacos de analogos de gaba.
EA201200428A1 (ru) Композиция и способ для лечения ожирения
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
WO2007027477A3 (en) Treating vulvodynia using prodrugs of gaba analogs
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
MX2009003022A (es) Composiciones y metodos para tratar picaduras de medusa.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal